Ad is loading...
DGSCX
Price
$43.03
Change
-$0.16 (-0.37%)
Updated
Nov 15 closing price
RSLDX
Price
$69.58
Change
-$0.86 (-1.22%)
Updated
Nov 15 closing price
Ad is loading...

DGSCX vs RSLDX

Header iconDGSCX vs RSLDX Comparison
Open Charts DGSCX vs RSLDXBanner chart's image
Virtus KAR Global Small-Cap Inst
Price$43.03
Change-$0.16 (-0.37%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World R5E
Price$69.58
Change-$0.86 (-1.22%)
VolumeN/A
CapitalizationN/A
DGSCX vs RSLDX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGSCX vs. RSLDX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGSCX is a Buy and RSLDX is a Buy.

FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 74.7B vs. DGSCX (47.2M). RSLDX (0.83) and DGSCX (0.82) have matching dividends . DGSCX was incepted earlier than RSLDX: DGSCX (28 years) vs RSLDX (9 years). DGSCX is a more actively managed with annual turnover of: 129.00 vs. RSLDX (29.00). RSLDX has a lower initial minimum investment than DGSCX: RSLDX (250) vs DGSCX (1000000). DGSCX (16.57) and RSLDX (16.23) have marching annual gain over last year. RSLDX return over 5 years is better than : 20.19 vs. DGSCX (-0.51).
DGSCXRSLDXDGSCX / RSLDX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years9 years-
Gain YTD6.9073.928176%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets47.2M74.7B0%
Annual Yield % from dividends0.820.8399%
Returns for 1 year16.5716.23102%
Returns for 3 years-28.76-25.42113%
Returns for 5 years-0.5120.19-3%
Returns for 10 years-0.30N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSA43.130.80
+1.89%
National Storage Affiliates Trust
CISS1.110.02
+1.83%
C3is
UTI19.610.07
+0.36%
Universal Technical Institute
TXT84.91-1.19
-1.38%
Textron
HRTX1.19-0.05
-4.03%
Heron Therapeutics